Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

End-of-day quote. End-of-day quote Toronto Stock Exchange - 07/03
11.75 CAD   +1.12%
06/29 CARDIOME PHARMA : SteadyMed and Cardiome Enter into a License Agreem..
06/24 CARDIOME PHARMA : Announces Voting Results
06/16 CARDIOME PHARMA : to Present at JMP Securities Healthcare Conference
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
06/25/2015 06/26/2015 06/29/2015 06/30/2015 07/03/2015 Date
11.45 11.57 11.29 11.62 11.75 Last
1190 2660 9200 1360 415 Volume
-0.35% +1.05% -2.42% +2.92% +1.12% Change
Financials ( CAD)
Sales 2015 41,3 M
EBIT 2015 -14,1 M
Net income 2015 -8,74 M
Debt 2015 -
Yield 2015 -
Sales 2016 52,0 M
EBIT 2016 -10,7 M
Net income 2016 0,53 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 4,78x
Capi. / Sales 2016 3,80x
Capitalization 198 M
More Financials
Company
Cardiome Pharma Corp. is a specialty pharmaceutical company, which engages in the discovery, development and commercialization of cardiovascular therapies that will improve the health of patients suffering from heart disease.Cardiome has two marketed, in-hospital, cardiology products, BRINAVESS,... 
Sector
Pharmaceuticals
Calendar
08/10Earnings Release
More about the company
Surperformance© ratings of Cardiome Pharma Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on CARDIOME PHARMA CORP
06/29 CARDIOME PHARMA : SteadyMed and Cardiome Enter into a License Agreement for the ..
06/24 CARDIOME PHARMA : Announces Voting Results
06/16 CARDIOME PHARMA : to Present at JMP Securities Healthcare Conference
06/12 CARDIOME PHARMA : Independent Study Finds Intravenous Vernakalant Facilitates El..
06/03 CARDIOME PHARMA : Appoints David Dean Vice President, Business Development and I..
05/13 CARDIOME PHARMA : Reports First Quarter 2015 Financial Results
05/12 CARDIOME PHARMA : and AOP Orphan Pharma Enter ESMOCARD Commercialization Agreeme..
05/07 CARDIOME PHARMA : To Hold First Quarter 2015 Financial Results Conference Call O..
More news
Sector news : Biopharmaceuticals
10:43a NOVARTIS : 'More efforts needed worldwide to prevent eye diseases'
01:00a OPKO HEALTH : and Bio-Reference Laboratories Announce Early Termination of the W..
07/03 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
More sector news : Biopharmaceuticals
News from SeekingAlpha
05/13 Cardiome Pharma's (CRME) CEO William Hunter on Q1 2015 Results - Earnings Cal..
05/13 Cardiome Pharma reports Q1 results
05/13 Cardiome Pharma beats by $0.07, misses on revenue
05/12 Notable earnings before Wednesday's open
03/12 Cardiome Pharma's (CRME) CEO William Hunter on Q4 2014 Results - Earnings Cal..


Comments 
Advertisement
Chart CARDIOME PHARMA CORP
Duration : Period :
Cardiome Pharma Corp Technical Analysis Chart | COM | CA14159U3010 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions